PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.\', \'Wuhan Huoshenshan Hospital, Wuhan, China.\', \'Department of Respiratory, Changzheng Hospital, Second Military Medical University, Shanghai, China.\', \'Optical Valley Branch of Maternal and Child Hospital of Hubei Province, Wuhan, China.\', \'Department of Hematology, Second Medical Center of Chinese PLA General Hospital, Beijing, China.\', \'Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China.\', \'Department of Infectious Disease, General Hospital of Central Theater Command, Wuhan, China.\', \'VCANBIO Cell & Gene Engineering Corp., Ltd, Tianjin, China.\', \'National Industrial Base for Stem Cell Engineering Products, Tianjin, China.\', \'Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\', \'Key Laboratory of Cancer Center, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.\', \'Department of Endocrinology and Metabolism, Changzheng Hospital, Second Military Medical University, Shanghai, China.\', \'Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\', \'Nursing Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.\', \'Immunotherapy Programme, Champalimaud Centre for the Unknown, Lisbon, Portugal.\', \'I Med Clinic, University of Mainz, Mainz, Germany.\', \'Center for Clinical Microbiology, Division of Infection and Immunity, University College London, and UCL Hospitals NIHR Biomedical Research Centre, London, UK.\', \'Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China. yaochen@hsc.pku.edu.cn.\', \'Optical Valley Branch of Maternal and Child Hospital of Hubei Province, Wuhan, China. weifenxie@medmail.com.cn.\', \'Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, Shanghai, China. weifenxie@medmail.com.cn.\', \'Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China. fswang302@163.com.\', \'Wuhan Huoshenshan Hospital, Wuhan, China. fswang302@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41392-021-00488-5
?:doi
?:hasPublicationType
?:journal
  • Signal transduction and targeted therapy
is ?:pmid of
?:pmid
?:pmid
  • 33568628
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33568628>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33568628>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all